Chapter 13 Flashcards
1
Q
The hallmark of schizophrenia is ___________
A
psychosis (loss of contact with reality)
2
Q
First clinical description of schizophrenia
A
- 1810, John Haslam (apothecary in first psychiatric institution in Europe)
3
Q
Benedict Morel ‘demence precoce’
A
- 1860
- described case of 13yo boy
- case had dementia features to it
- thought boys’ intellectual, moral, and physical functions deteriorated bc of brain degeneration of hereditary origin
4
Q
Emil Kraepelin ‘dementia praecox’
A
- latin for demence precoce
- mental deterioration at an early age
- noted disorder characterized by hallucinations, apathy/indifference, withdrawn behavior, incapacity of regular work
- best known early definition
5
Q
Eugen Bleuler (1857-1939)
A
- coined term schizophrenia
- schizo = to split; phren = mind
- disorder is lack of coherence between thought and emotion; to split from reality
6
Q
Schizophrenia DSM-5 Criteria
A
- 2+ of symptoms present for at least 1mo
- delusions
- hallucinations
- disorganized speech
- grossly disorganized/catatonic behavior
- negative symptoms (ie dim. emotional expression)
7
Q
Lifetime prevalence of schizophrenia
A
just under 1% (0.7%)
8
Q
Risk factors for schizophrenia
A
- having father over 50 (at conception)
- parent in dry cleaning business
- first/second generation immigrants (esp Black Caribbean/African ppl living in white communities)
9
Q
Onset of schizophrenia
A
- 18-30 (more likely early onset in men)
- more common/severe in men
- second and third peak in mid 40s and ealy 60s in women
- low estrogen worsens symptoms so might play a protective role in women
10
Q
Delusions
A
- erroneous belief fixed/firmly held despite clear contradictory evidence (disturbance in content of thought)
- more than 90% of patients have them at some point
- ex thoughts being broadcast/inserted/taken away; neutral env. having special meaning; bodily changes/removal of organs
11
Q
Hallucinations
A
- sensory experience that seems real but occurs in absence of any external perceptual stimulus
- auditory most common (75% of patients)
- likely that auditory hallucinations occur when patients misinterpret self-generated thoughts as coming from another source (show activation of Broca’s area-speech production-and not speech comprehension areas)
- visual in 39%
- patients become emotionally involved in hallucinations; incorporate them into delusions
12
Q
Disorganized speech
A
- disorder in thought form (delusions are disorder of thought content)
- fail to make sense even though they are using language in conventional way
- may make up new words (neologisms)
13
Q
Disorganized behavior
A
- elements of this often present in children even when no other symptoms are there yet
- impairment of goal-directed activity
- ex issues w hygiene, silliness, unusual dress
- catatonia: almost no movement
- catatonic stupor: virtual absence of all mvmt+speech
14
Q
Positive symptoms of schizophrenia
A
- excess/distortion in normal behavior and experience
- “what there is more of”
- delusions, hallucinations
- most medications work primarily on positive symptoms!
15
Q
Negative symptoms of schizophrenia
A
- absence/deficit of normally present behaviors
- reduced expressive behavior (ie blunted affect, alogia-little speech)
- reduced motivation/experience of pleasure (avolition/anhedonia)
- presence of negative symptoms not a good sign
16
Q
Schizoaffective Disorder
A
- features of schizophrenia AND severe mood disorder
- “schizophrenia w a lot of emotional distress”
- poor diagnostic reliability
- moving toward needing to be in full depressive episode for diagnosis
- 10y outcome better than for schizophrenia patients
17
Q
Schizophreniform Disorder
A
- schizophrenia-like symptoms lasting at least 1mo but less than 6mo
- basically less severe form of schizophrenia
- prognosis better than for schizophrenia
18
Q
Delusional Disorder
A
- delusional beliefs w otherwise normal behavior
- erotomania delusion involves great love for someone (usually high status) – lots of stalkers!
- like nano-robots in covid vaccine thing
19
Q
Brief Psychotic Disorder
A
- sudden onset of psychotic symptoms/disorganized speech/catatonic behavior
- typically lasts a few days
- usually triggered by high stress situation
20
Q
Familial factors of schizophrenia
A
- tend to run in families (familial)
- prevalence in first-degree relatives is 10%
- second-degree relatives (share 25% of DNA) have 3% prevalence
- familial =/= genetic
- risk for identical twins is close to 50%
- this and bipolar are most genetically based disorders
21
Q
Twin/adoption studies in schizophrenia
A
- concordance rate for MZ twins 28%, DZ twins 6%
- higher rates when biological parent has schizophrenia
- kids at high genetic risk raised in healthy environment ( and low-communication-deviance) don’t develop problems more than kids at low genetic risk
- so genetic risk + adverse environment is very bad!
22
Q
Molecular genetics and schizophrenia
A
- probably involves many genes
- candidate genes: havent rly been identified
- genome-wide association study (GWAS) looks for profiles of aberrant genetic code (found 103 loci ass. w schizophrenia)
- COMT gene on chromosome 22 involved in dopamine metabolism (more likely to develop schizophrenia if gen. material del. or w cannabis use in adolescence)
- strongest finding is region on chromosome 6 (genes involved in immune functioning)
- some risk alleles also implicated in bipolar
23
Q
Endophenotypes and schizophrenia
A
- trait that individuals who have this condition tend to have
- often present before individual develops condition
- discrete, stable, measurable trait thought to be under genetic control
24
Q
Prenatal exposure in schizophrenia
A
- higher rates in children born to mothers in second trimester at time of influenza epidemic (viral infection during pregnancy can increase risk!)
- rhesus incompatibility between mother and infant can increase risk of brain abnormalities
25
Q
Pregnancy/birth complications and schizophrenia
A
- delivery problems that affect oxygen supply are risk
- could be triggered by early nutritional deficiency
- SLE late in 1st trimester/early in 2nd
26
Q
Attenuated psychosis syndrome
A
- new in DSM5 as disorder in need of futher study
- focus on prodromal (very early) signs
- ppl with this syndrome at risk for later psychosis
- commonly perplexed by reality (eg mix up dreams and reality)
27
Q
Neurocognition in schizophrenia
A
- cognitive impairment is core feature
- almost all aspects of cognition are impaired
- lower IQ may be risk factor; higher IQ may be protective
- sharp decline occurs during transition from premorbid period to full-blown illness
- often see poor reaction times, poor Pro50 suppression (no habituation to sounds), eye tracking dysfunction (might be useful endophenotype for genetic studies)
28
Q
Social cognition in schizophrenia
A
- significant impairments
- failure to recognize social hints
- difficulty recognizing emotions in faces/speech
29
Q
Loss of brain volume in schizophrenia
A
- enlarged brain ventricles (more in males) is indicator of reduction in brain tissue
- decrease in volume present early in illness
- progressive deterioration for many years
- psychosis and cortical thinning go together
- gradual loss of gray matter in multiple regions (study found 3% decrease in 1y)
30
Q
Affected brain regions in schizophrenia
A
Reduction of frontal and temporal lobes (memory, decision-making, processing auditory memory)
- prefrontal cortex
- medial temporal areas (decision-making)
- amygdala (emotion)
- hippocampus (memory)
- thalamus (sensory input)
- cause of abnormal brain structure unclear; might be related to stage of illness, medications
31
Q
White matter problems in schizphrenia
A
- white matter important for connectivity of the brain
- abnormalities correlated w cognitive impairments
- reductions in volume AND structural abnormalities (abnormalities in first-episode patients and genetic high risk ppl)
- like if electrical wire system lost insulating coating
32
Q
Brain functioning in schizophrenia
A
- hypofrontality (deficits to organize info and take action)
- impaired functioning of frontal lobes esp in early stages and those at high risk
- dysfunction of temporal lobes (how activity in diff. regions gets coordinated)
33
Q
Cytoarchitecture in schizophrenia
A
- if cells don’t migrate properly, cytoarchitecture is compromised (increase in neural density in some areas)
- abnormal distribution of cells in cortex and hippocampus
- missing inhibitory interneurons (so can’t regulate overactivity)
34
Q
Brain development in adolescence and schizophrenia
A
- major brain injuries in this period increase risk of developing schizophrenia
- ppl hospitalized for head injury have 65% increased risk
- if injured between 11-15 risk increased by 85%
35
Q
Psychosocial and cultural aspects of schizophrenia
A
- past theory that family was to blame (conflicting messaging communication style) but no empirical evidence
- if not genetically at risk, adverse env has little effect
36
Q
Expressed Emotion (EE) and schizophrenia
A
- measure of family environment based on how family member speaks ab patient in interview
- 3 elements: criticism, hostility, emotional overinvolvement (EOI)
- High-EE homes >2x chance of relapse (esp for chronically ill patients)
- still don’t know exactly how it affects the brain
37
Q
Urban living as a risk factor for schizophrenia
A
- kids who spent first 15y in urban settign 2.75x more likely to develop schizophrenia
- estimated if we all lived in rural settings number of cases would decrease by 30%
38
Q
Immigration and schizophrenia
A
- recent immigrants at much higher risk
- darker skin more at risk
- no evidence this can be explained by cultural misunderstandings
- ppl who feel discriminated against more likely to develop psychotic symptoms
39
Q
Cannabis use and schizophrenia
A
- ppl w schizophrenia 2x more likely to smoke cannabis (might be correlate not cause)
- majority of cannabis users never develop schizophrenia
- might accelerate progressive brain changes
40
Q
Diathesis-Stress model of schizophrenia
A
- genetic predispositions shaped by environmental factors (prenatal exposures, infections, stressors)
- genetic factors+prenatal/perinatal env.=brain vulnerability
- stress+developmental maturation processes act on brain vulnerability and lead to psychosis
41
Q
Nongenetic risk factors for schizophrenia (7)
A
- older father
- virus exposure
- obstetric complications
- urban upbringing
- head injury
- cannabis use
- migrant status
42
Q
Neurochemistry and schizophrenia
A
Dopamine linked to schizophrenia
- chlorpromazine blocks dopamine receptors (helps reduce psychosis)
- amphetamines produce excess dopamine and mimic psychotic state
- L-DOPA used in Parkinson’s might cause psychosis
Glutamate
- excitatory neurotransmitter
- when receptors blocked, schizophrenia-like symptoms (PCP and ketamine do this)
43
Q
Pharmacological treatments of schizophrenia
A
- first gen antipsychotics (block action of dopamine); neuroleptics like chlorpromazine and haloperidol
- second gen antipsychotics (less parkinson-ish side effects)
- research on role of estrogen
44
Q
Second-gen antipsychotics
A
- block dopamine receptors more selectively
- less likelihood of extrapyramidal (motor) side effects
- clozapine, olanzapine, risperidone, ziprasidone
45
Q
Clinical outcomes of schizophrenia
A
- not favourable; lifelong condition
- 38% of patients thought of as recovered 15-25y after development of disorder (less delusions/hallucinations but don’t go back to normal)
- about 12% of patients need long-term institutionalization
- men die 14.6y earlier
- women w schizoaffective die 17.5y earlier
46
Q
Neuropleptic Malignant Syndrome
A
- life-threatening idiosyncratic rxn to antipsychotic drugs
- fever, altered mental status, muscle rigidity, autonomic dysfunction
- associated w virtually all neuroleptics (incl newer atypical antipsychotics and other meds that affect central dopaminergic neurotransmission
47
Q
Estrogen treatment and schizophrenia
A
- PANSS positive symptom scores go down with estrogen treatment over 28 days vs placebo
48
Q
Patient perspectives in schizophrenia
A
- not all benefit from antipsychotics
- side-effects can lead to discontinued meds
- need other interventions (ie social skills)
- might avoid taking meds bc it confirms they are mentally ill
49
Q
Treatment approaches in schizophrenia
A
- Case management (coordinating services)
- Family therapy
- Psychoeducation
- Social-skills training (transitional living unit)
- Cognitive remediation (training cognitive skills)
- CBT (address delusions)
- Exercise
